UCB is a global biopharmaceutical company inspired by the needs of people living with severe diseases. As a global leader, UCB focuses on creating valuable solutions that improve the lives of those affected by neurological and autoimmune conditions.

Believing that everyone deserves the best possible quality of life, UCB works to deliver sustainable, life-enhancing medicines. The company recognizes that a healthier and fairer future requires collective action and actively collaborates with patients, caregivers, healthcare professionals, and other stakeholders who understand the challenges of severe diseases.

At the heart of UCB’s work is a commitment to crafting sustainable solutions, improving health equity, and minimizing environmental impact.

UCB’s mission is powered by more than 9,000 employees across nearly 40 countries, with headquarters in Belgium. Since 1928, its people have advanced biopharmaceutical research, invested in innovation, and pursued meaningful impact—driving progress for those they serve and shaping a healthier future.

‍